Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection

A real-world perspective and review of the literature

A. Babiker, L. Clarke, Yohei Doi, Ryan K. Shields

研究成果: Article

抄録

Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 hours and 14 days, respectively. Response rates did not vary across pathogens. Our retrospective, observational findings support fosfomycin treatment against MDR pathogens causing UTIs.

元の言語English
ジャーナルDiagnostic Microbiology and Infectious Disease
DOI
出版物ステータスPublished - 01-01-2019

Fingerprint

Fosfomycin
Urinary Tract Infections
Bacteria
Therapeutics

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

これを引用

@article{d8a2682773fe4f90a8da28b9fdd88445,
title = "Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection: A real-world perspective and review of the literature",
abstract = "Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87{\%} and 94{\%} at 48 hours and 14 days, respectively. Response rates did not vary across pathogens. Our retrospective, observational findings support fosfomycin treatment against MDR pathogens causing UTIs.",
author = "A. Babiker and L. Clarke and Yohei Doi and Shields, {Ryan K.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.diagmicrobio.2019.06.008",
language = "English",
journal = "Diagnostic Microbiology and Infectious Disease",
issn = "0732-8893",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Fosfomycin for treatment of multidrug-resistant pathogens causing urinary tract infection

T2 - A real-world perspective and review of the literature

AU - Babiker, A.

AU - Clarke, L.

AU - Doi, Yohei

AU - Shields, Ryan K.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 hours and 14 days, respectively. Response rates did not vary across pathogens. Our retrospective, observational findings support fosfomycin treatment against MDR pathogens causing UTIs.

AB - Among 47 patients with urinary tract infections (UTIs) due to multidrug-resistant (MDR) bacteria, treatment with fosfomycin resulted in clinical cure rates of 87% and 94% at 48 hours and 14 days, respectively. Response rates did not vary across pathogens. Our retrospective, observational findings support fosfomycin treatment against MDR pathogens causing UTIs.

UR - http://www.scopus.com/inward/record.url?scp=85068776483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068776483&partnerID=8YFLogxK

U2 - 10.1016/j.diagmicrobio.2019.06.008

DO - 10.1016/j.diagmicrobio.2019.06.008

M3 - Article

JO - Diagnostic Microbiology and Infectious Disease

JF - Diagnostic Microbiology and Infectious Disease

SN - 0732-8893

ER -